Latest Breaking News On - David nassif - Page 3 : comparemela.com

Sio Gene Therapies to Liquidate after Failing to Find a Buyer

Sio Gene Therapies to Liquidate after Failing to Find a Buyer
globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.

Tay sachs sandhoffPavan cheruvuDavid nassifUniversity of massachusettsRare dailyGene therapiesSio gene therapies

Sio Gene Therapies Inc Announces Board Approval of Plan of

NEW YORK, Dec. 14, 2022 (GLOBE NEWSWIRE) Sio Gene Therapies Inc. (Nasdaq:SIOX) today announced that its Board of Directors has determined, after.

United statesDavidw nassifDavid nassifExchange commissionExchange commission onSio gene therapies incGene therapiesChief executiveComplete liquidationNasdaq capital marketAnnual reportPrivate securities litigation reform actQuarterly reportExecutive officerChief financialNasdaq siox

Sio Gene Therapies (SIOX) Announces Board Approval of Plan of Complete Liquidation and Dissolution

Sio Gene Therapies (SIOX) Announces Board Approval of Plan of Complete Liquidation and Dissolution
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDavid nassifExchange commissionSio gene therapies incGene therapiesChief executiveComplete liquidationNasdaq capital market

Sio Gene Therapies Announces Fiscal First Quarter 2022 Financial Results

Sio Gene Therapies Announces Fiscal First Quarter 2022 Financial Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

David nassifExchange commissionUniversity of massachusettsExchange commission onNational human genome research instituteDavidw nassifsio gene therapies incSio gene therapies incGene therapiesChief executive officerSio geneOxford agreementPrivate securities litigation reform actAnnual reportChief financial officerConsolidated statementsMonths ended june

Signs of Trouble Emerge as Sio Gene Halts UMass Gangliosidosis Deal

Sio Gene has terminated its licensing deal with the UMass to develop and commercialize two gene therapy product candidates to focus on more potentially profitable projects.

Oxford biomedicaPavan cheruvuDavid nassifUniversity of massachusettsGene therapiesIgns of trouble emerge as sio gene halts umass gangliosidosis deal